Home › Funds › Eversept Partners, LP › THC
Eversept Partners, LP position in THC
TENET HEALTHCARE CORP · Health Care
Eversept Partners, LP reported holding 114,199 shares of THC (TENET HEALTHCARE CORP) in its Q2 2026 13F filing — a position valued at US$21.4M, representing 1.12% of its reported portfolio and ranking #25 among its reported holdings. Eversept Partners, LP has disclosed THC holdings in 4 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's THC position evolved
Eversept Partners, LP first disclosed a stake in THC in Q4 2023 at 187,265 shares (US$14.2M). The position peaked in Q2 2026 at 114,199 shares, worth US$21.4M. Across 4 filings, Eversept Partners, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 114,199 shares valued at US$21.4M — an increase of 84,687 shares quarter over quarter.. Notable position changes include a 287% increase in Q2 2026 (shares rose 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 187.26K | $14.15M | New |
| Q1 2024 | 175.63K | $18.46M | Reduce |
| Q1 2026 | 29.51K | $5.57M | New |
| Q2 2026 | 114.20K | $21.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 40 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$168.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.43M sh · $829.06M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 2.24M sh · $418.25M · Q2 2026
- MANNING & NAPIER ADVISORS LLC 901.64K sh · $168.76M · Q2 2026
- EMINENCE CAPITAL, LP 790.30K sh · $149.14M · Q1 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held THC?
Eversept Partners, LP has disclosed THC holdings in 4 of the last 11 reported quarters, going back to Q4 2023.
What is Eversept Partners, LP's current position in THC?
As of Q2 2026, Eversept Partners, LP holds 114.20K shares of THC (TENET HEALTHCARE CORP), valued at $21.36M, representing 1.12% of its reported portfolio and ranking #25.
Has Eversept Partners, LP been buying or selling THC?
In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in THC. The position peaked in Q2 2026 at 114.20K shares.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.